1. NR re: Ph. 1b terminated early due to achieving primary and secondary endpoints.
2. FDA Fast Track NR (showing FDA recognizes the potential superiority of Theralase PDT over current standard of care)
3. Latest Quarterly Newsletter with an update on Ph2 results and the opening of the first 4 US study sites
4. Pre-clinical rat studies are fascinating as well... (100% kill rate across the board, hinting at blockbuster potential in humans that we are well on the way to confirming.)


BlueFranky wrote: To everyone concerned If someone close to you expressed an interest in reading the most compelling pieces of information, pointing toTLT ad a case of when, not if... which links would you provide? Thank you in advance